Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2026-01-06 @ 3:08 PM
Study NCT ID:
NCT04053634
Status:
COMPLETED
Last Update Posted:
2025-08-19
First Post:
2019-07-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-26
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-07-28
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-16
First Submit QC Date:
None
Study First Post Date:
2019-08-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-18
Last Update Post Date:
2025-08-19
Last Update Post Date Type:
ACTUAL